In this third of four videos on the topic of cellular therapies for the hematologic malignancies, Carl H June, MD, describes the case of Emily Whitehead, the first pediatric patient treated with CAR T cell therapy for resistant, refractory acute lymphoblastic leukemia (ALL). Emily is now in her fourth year of complete remission. Dr. June also discusses the ELIANA study now ongoing in pediatric patients with relapsed and refractory B-cell ALL.
To view other parts of this program:
Part 1: Adoptive Cell Therapy - An Introduction
Part 2: CTL019 Therapy in Chronic Lymphocytic Leukemia
Part 4: Adoptive Cell Therapy - Lessons Learned, Issues and the Future